SlideShare ist ein Scribd-Unternehmen logo
1 von 13
Downloaden Sie, um offline zu lesen
Insulin
By
Dr. Jasmine Chaudhary
Associate Prof.
MMCP
• Insulin is a polypeptide hormone secreted from beta cells of Islets of
Langerhans of pancreas.
• It is mainly responsible for regulating blood glucose level in the body by
controlling carbohydrate, fat and protein metabolism.
• The normal blood glucose level is (As per ADA)
• If the blood sugar level becomes low, it leads to hypoglycemia and if it get
increases, it leads to hyperglycemia or DIABETES MELLITUS.
• Diabetes mellitus is derived from the Greek word diabetes meaning siphon -
to pass through and the Latin word mellitus meaning honey or sweet. This is
because in diabetes excess sugar is found in blood as well as the urine.
Normal person Diabetic person
Fasting 70-100mg/dl 80-130mg/dl
Post prandial Less than 140mg/dl Less than 180mg/dl
Islets of Langerhans
δ-cells
β-cells P-cells
Îą-cells
Increase glucose
level
Decrease glucose
level
Secrete glucagon
Secrete
Somatostatin
Inhibit both insulin
and glucagon
Pancreatic
polypeptide
Secrete insulin
• Diabetes mellitus is a group of metabolic diseases characterized by hyperglycemia
resulting from defects in insulin secretion, insulin action, or both.
• If left untreated, it may lead to several complications like diabetic nephropathy,
retinopathy, heart diseases, stroke, foot ulcers and damage to eyes.
• Diabetes generally occurs, when pancreas is not able to either produce sufficient
insulin or body is not able to utilize sufficient insulin or both.
• Depending on, diabetes mellitus is divided into 2 main types
 Insulin dependent diabetes mellitus (IDDM)/ Type-I DM
 Non-insulin dependent diabetes mellitus (NIDDM)/ Type-2 DM
Type-I DM
• Pancreas lack the ability to synthesize/release insulin.
• Also known as Juvenile diabetes because it often begins in childhood.
• The cause is generally unknown.
• It is mainly an autoimmune condition which is caused by body
attacking its own pancreas with antibodies so damaged pancreas is not
able to produce enough insulin.
• Insulin therapy is the only treatment.
• No family history so may or may not be hereditary.
• Obesity is generally not the cause.
Type-II DM
• In this body is incapable of utilizing the synthesized insulin or insulin
secretion is not sufficient.
• Also known as adult onset diabetes as it generally begins after
adulthood.
• Primary cause is excessive body weight and not proper exercise.
• Oral hypoglycemic agents can be helpful.
• Most common type and generally hereditary.
A third type of diabetes mellitus generally occurs during pregnancy and it
is known as GESTATIONAL diabetes.
• It may occur in a woman without a previous history of diabetes.
• Unexplained weight loss and sometimes weight gain
• Polydipsia
• Polyphagia
• Polyuria
• Excessive fatigue/ lethargy
• Slow healing
• Excessive sleep
• Blurred vision
• Glucosuria
• Itchy skin
• Ketonemia
• Astouria
• Prolonged high glucose level may lead to glucose absorption in lens
of eye, leading to change in shape and result in vision changes.
Insulin
• Longest polypeptide of known structure (Mol wt: more than 6000).
• Term insulin was coined by DeMeyer in 1909 and sequence of amino
acids in insulin was characterized by Sanger in 1956.
Structure of Insulin
Made up of 2 Amino acid chain: Chain A and Chain B
Chain A : consists of 21 Aa
Chain B: Consists of 30 Aa
So Total 51 Aa are present in insulin. Both chains are linked to each other
by 2 disulfide bonds
• Ist Bridge: 7th Aa (Cysteine) of chain A with 7th Aa (Cysteine) of Chain
b
• 2nd Bridge: 20th Aa (Cysteine) of chain A with 19th Aa (Cysteine) of
Chain b
• 3rd bridge: within chain A itself (6th and 11th Aa of chain A)
Structure of Insulin
SAR of insulin
• Removal of Aa from chain A reduce activity.
• Aa from 1-6 and 26-30 from chain B: can be removed without
significantly effecting activity.
• There should be specific relationship between confirmation
and activity of insulin. So, any change in configuration leads to
loss of activity.
• Any modification of side chain carboxylic or tyrosine residues
decrease activity.
Biosynthesis of Insulin
Preproinsulin Preinsulin
(Precursor present in ribosomes
of ER of pancreatic beta cells) Protease
Insulin +4 Aa+ C-peptide
Combine with Zn and stored in form of granulated Zn vesicles
Breakage of storage vesicles
Release of insulin
Ca
Physiological functions of insulin
Carbohydrate metabolism: In normal amount, regulates gluconeogenesis and
glycogenolysis.
• Deficiency may lead to increased gluconeogenesis and glycogenolysis
leading to increased glucose level.
Fat metabolism: Promotes lipogenesis
• Deficiency may lead to increased mobilization of fats from adipose tissue
into blood, thereby increasing free fatty acid in blood which in turn
increase acetoacetic acid, ketone bodies, beta-hydroxy butyric acid leading
to ketoacidosis.
Protein metabolism
• Deficiency leads to breaking of proteins from muscles leading to muscle
Limitations of Insulin
• Insulin can’t be taken orally due to its proteinaceous nature so
metabolized by enzymes like pepsin, trypsin.
• On long term therapy, oedema at site of injection.
• Insulin therapy fails to give expected results, if there is no diet
control/exercise.
• If dose of insulin is not scheduled properly, fluctuations in blood
glucose levels leads to visual disturbances like cataract and there may
chances of hypoglycemic shock.

Weitere ähnliche Inhalte

Was ist angesagt?

Protein binding of drug.ppt
Protein binding of drug.pptProtein binding of drug.ppt
Protein binding of drug.pptramchoure90
 
Chaloramphenicol as an antibiotic
Chaloramphenicol as an antibioticChaloramphenicol as an antibiotic
Chaloramphenicol as an antibioticMuhammad Mudassir
 
Insulin and antidiabetics
Insulin and antidiabeticsInsulin and antidiabetics
Insulin and antidiabeticsDrVishal Kandhway
 
4th unit thyroid and antithyroid drugs
4th unit thyroid and antithyroid drugs4th unit thyroid and antithyroid drugs
4th unit thyroid and antithyroid drugsNikithaGopalpet
 
Antipsychotics Med chem lecture
Antipsychotics Med chem lecture Antipsychotics Med chem lecture
Antipsychotics Med chem lecture sagar joshi
 
ANTI HYPERTENSIVE AGENTS [MEDICINAL CHEMISTRY] BY P.RAVISANKAR, HYPERTENSION,...
ANTI HYPERTENSIVE AGENTS [MEDICINAL CHEMISTRY] BY P.RAVISANKAR, HYPERTENSION,...ANTI HYPERTENSIVE AGENTS [MEDICINAL CHEMISTRY] BY P.RAVISANKAR, HYPERTENSION,...
ANTI HYPERTENSIVE AGENTS [MEDICINAL CHEMISTRY] BY P.RAVISANKAR, HYPERTENSION,...Dr. Ravi Sankar
 
Tetracycline sar
Tetracycline sarTetracycline sar
Tetracycline sarnaseefa
 
Antihyperlipidemic drugs
Antihyperlipidemic drugsAntihyperlipidemic drugs
Antihyperlipidemic drugsLikhita Kolli
 
Hypoglycemic agents
Hypoglycemic agentsHypoglycemic agents
Hypoglycemic agentsAshishVerma571
 
DRUG METABOLISM-MEDICINAL CHEMISTRY
DRUG METABOLISM-MEDICINAL CHEMISTRYDRUG METABOLISM-MEDICINAL CHEMISTRY
DRUG METABOLISM-MEDICINAL CHEMISTRYNavdha Soni
 
THEORIES OF DRUG RECEPTOR INTERACTION
THEORIES OF DRUG RECEPTOR INTERACTIONTHEORIES OF DRUG RECEPTOR INTERACTION
THEORIES OF DRUG RECEPTOR INTERACTIONAbhishek Ghara
 
Testosterone hormone - Medicinal Chemistry
Testosterone hormone - Medicinal ChemistryTestosterone hormone - Medicinal Chemistry
Testosterone hormone - Medicinal ChemistryFaizan Akram
 
Factors Affecting Protein-Binding of Drugs
Factors Affecting Protein-Binding of DrugsFactors Affecting Protein-Binding of Drugs
Factors Affecting Protein-Binding of Drugswonderingsoul114
 
STEROIDS - MEDICINAL CHEMISTRY
STEROIDS - MEDICINAL CHEMISTRYSTEROIDS - MEDICINAL CHEMISTRY
STEROIDS - MEDICINAL CHEMISTRYSabaMustafa11
 
SAR and Synthesis of adrenergic blockers
SAR and Synthesis of adrenergic blockersSAR and Synthesis of adrenergic blockers
SAR and Synthesis of adrenergic blockersDrParthiban1
 
Sar of Penicillin and cephalosporin
Sar of Penicillin and cephalosporinSar of Penicillin and cephalosporin
Sar of Penicillin and cephalosporinRanjanaKumari33
 
Asthma ppt1 PHARMACY
Asthma ppt1 PHARMACYAsthma ppt1 PHARMACY
Asthma ppt1 PHARMACYSemiyya Semi
 

Was ist angesagt? (20)

Protein binding of drug.ppt
Protein binding of drug.pptProtein binding of drug.ppt
Protein binding of drug.ppt
 
Chaloramphenicol as an antibiotic
Chaloramphenicol as an antibioticChaloramphenicol as an antibiotic
Chaloramphenicol as an antibiotic
 
Diuretics
DiureticsDiuretics
Diuretics
 
Insulin and antidiabetics
Insulin and antidiabeticsInsulin and antidiabetics
Insulin and antidiabetics
 
4th unit thyroid and antithyroid drugs
4th unit thyroid and antithyroid drugs4th unit thyroid and antithyroid drugs
4th unit thyroid and antithyroid drugs
 
Cardiac glycosides
Cardiac glycosidesCardiac glycosides
Cardiac glycosides
 
Antipsychotics Med chem lecture
Antipsychotics Med chem lecture Antipsychotics Med chem lecture
Antipsychotics Med chem lecture
 
ANTI HYPERTENSIVE AGENTS [MEDICINAL CHEMISTRY] BY P.RAVISANKAR, HYPERTENSION,...
ANTI HYPERTENSIVE AGENTS [MEDICINAL CHEMISTRY] BY P.RAVISANKAR, HYPERTENSION,...ANTI HYPERTENSIVE AGENTS [MEDICINAL CHEMISTRY] BY P.RAVISANKAR, HYPERTENSION,...
ANTI HYPERTENSIVE AGENTS [MEDICINAL CHEMISTRY] BY P.RAVISANKAR, HYPERTENSION,...
 
Tetracycline sar
Tetracycline sarTetracycline sar
Tetracycline sar
 
Antihyperlipidemic drugs
Antihyperlipidemic drugsAntihyperlipidemic drugs
Antihyperlipidemic drugs
 
Hypoglycemic agents
Hypoglycemic agentsHypoglycemic agents
Hypoglycemic agents
 
DRUG METABOLISM-MEDICINAL CHEMISTRY
DRUG METABOLISM-MEDICINAL CHEMISTRYDRUG METABOLISM-MEDICINAL CHEMISTRY
DRUG METABOLISM-MEDICINAL CHEMISTRY
 
THEORIES OF DRUG RECEPTOR INTERACTION
THEORIES OF DRUG RECEPTOR INTERACTIONTHEORIES OF DRUG RECEPTOR INTERACTION
THEORIES OF DRUG RECEPTOR INTERACTION
 
Testosterone hormone - Medicinal Chemistry
Testosterone hormone - Medicinal ChemistryTestosterone hormone - Medicinal Chemistry
Testosterone hormone - Medicinal Chemistry
 
Factors Affecting Protein-Binding of Drugs
Factors Affecting Protein-Binding of DrugsFactors Affecting Protein-Binding of Drugs
Factors Affecting Protein-Binding of Drugs
 
Hypoglycemic agents
Hypoglycemic agentsHypoglycemic agents
Hypoglycemic agents
 
STEROIDS - MEDICINAL CHEMISTRY
STEROIDS - MEDICINAL CHEMISTRYSTEROIDS - MEDICINAL CHEMISTRY
STEROIDS - MEDICINAL CHEMISTRY
 
SAR and Synthesis of adrenergic blockers
SAR and Synthesis of adrenergic blockersSAR and Synthesis of adrenergic blockers
SAR and Synthesis of adrenergic blockers
 
Sar of Penicillin and cephalosporin
Sar of Penicillin and cephalosporinSar of Penicillin and cephalosporin
Sar of Penicillin and cephalosporin
 
Asthma ppt1 PHARMACY
Asthma ppt1 PHARMACYAsthma ppt1 PHARMACY
Asthma ppt1 PHARMACY
 

Ähnlich wie Insulin.pdf

Antidiabetic agents
Antidiabetic agentsAntidiabetic agents
Antidiabetic agentspravin bendle
 
DIABETES MELLITUS.ppt
DIABETES MELLITUS.pptDIABETES MELLITUS.ppt
DIABETES MELLITUS.pptsmaskuklolo
 
Anti diabeticdrugs
Anti diabeticdrugsAnti diabeticdrugs
Anti diabeticdrugsDaniel Wang
 
Glucose regulation
Glucose regulationGlucose regulation
Glucose regulationSng Kim Sia
 
JUVENILE DIABETES MELLITUS.pptx
JUVENILE DIABETES MELLITUS.pptxJUVENILE DIABETES MELLITUS.pptx
JUVENILE DIABETES MELLITUS.pptxVIJI.V.S
 
Diabetes.pdf
Diabetes.pdfDiabetes.pdf
Diabetes.pdfJustinMutua
 
Diabetes mellitus
Diabetes mellitusDiabetes mellitus
Diabetes mellitusAliya Emil
 
Diabetes Mellitus.pptx
Diabetes Mellitus.pptxDiabetes Mellitus.pptx
Diabetes Mellitus.pptxGhaffarAhmed9
 
Drugs for diabetes - Pharmacology
Drugs for diabetes - PharmacologyDrugs for diabetes - Pharmacology
Drugs for diabetes - PharmacologyAreej Abu Hanieh
 
Diabetes Mellitus
Diabetes MellitusDiabetes Mellitus
Diabetes MellitusDJ CrissCross
 
Anti diabetic agents,Medicinal Chemistry,Mr.Jimmy Alexander ,Associate Profes...
Anti diabetic agents,Medicinal Chemistry,Mr.Jimmy Alexander ,Associate Profes...Anti diabetic agents,Medicinal Chemistry,Mr.Jimmy Alexander ,Associate Profes...
Anti diabetic agents,Medicinal Chemistry,Mr.Jimmy Alexander ,Associate Profes...JIMMYALEX8
 
INSULIN.pptx
INSULIN.pptxINSULIN.pptx
INSULIN.pptxShaik Anjum
 
Antidiabetic drugs
Antidiabetic drugsAntidiabetic drugs
Antidiabetic drugsDr. Pramod B
 
antidiabeticdrugs-150825103952-lva1-app6892.pdf
antidiabeticdrugs-150825103952-lva1-app6892.pdfantidiabeticdrugs-150825103952-lva1-app6892.pdf
antidiabeticdrugs-150825103952-lva1-app6892.pdfBucky10
 
Lesson plan of teaching and learning.pptx
Lesson plan of teaching and learning.pptxLesson plan of teaching and learning.pptx
Lesson plan of teaching and learning.pptxRashidahabib1
 
Antidiabetic agents
Antidiabetic agentsAntidiabetic agents
Antidiabetic agentskhalilUllah26
 
Assessment Of Pancreatic Hormones In Diabetes Mellitus & Non-diabetes Mellitu...
Assessment Of Pancreatic Hormones In Diabetes Mellitus & Non-diabetes Mellitu...Assessment Of Pancreatic Hormones In Diabetes Mellitus & Non-diabetes Mellitu...
Assessment Of Pancreatic Hormones In Diabetes Mellitus & Non-diabetes Mellitu...Rahul Gautam
 

Ähnlich wie Insulin.pdf (20)

Antidiabetic agents
Antidiabetic agentsAntidiabetic agents
Antidiabetic agents
 
DIABETES MELLITUS.ppt
DIABETES MELLITUS.pptDIABETES MELLITUS.ppt
DIABETES MELLITUS.ppt
 
Anti diabeticdrugs
Anti diabeticdrugsAnti diabeticdrugs
Anti diabeticdrugs
 
Glucose regulation
Glucose regulationGlucose regulation
Glucose regulation
 
JUVENILE DIABETES MELLITUS.pptx
JUVENILE DIABETES MELLITUS.pptxJUVENILE DIABETES MELLITUS.pptx
JUVENILE DIABETES MELLITUS.pptx
 
type 2 diabetes
type 2 diabetestype 2 diabetes
type 2 diabetes
 
Diabetes.pdf
Diabetes.pdfDiabetes.pdf
Diabetes.pdf
 
Anti diabetic drugs
Anti diabetic drugsAnti diabetic drugs
Anti diabetic drugs
 
Diabetes mellitus
Diabetes mellitusDiabetes mellitus
Diabetes mellitus
 
Diabetes Mellitus.pptx
Diabetes Mellitus.pptxDiabetes Mellitus.pptx
Diabetes Mellitus.pptx
 
Drugs for diabetes - Pharmacology
Drugs for diabetes - PharmacologyDrugs for diabetes - Pharmacology
Drugs for diabetes - Pharmacology
 
Diabetes Mellitus
Diabetes MellitusDiabetes Mellitus
Diabetes Mellitus
 
Anti diabetic agents,Medicinal Chemistry,Mr.Jimmy Alexander ,Associate Profes...
Anti diabetic agents,Medicinal Chemistry,Mr.Jimmy Alexander ,Associate Profes...Anti diabetic agents,Medicinal Chemistry,Mr.Jimmy Alexander ,Associate Profes...
Anti diabetic agents,Medicinal Chemistry,Mr.Jimmy Alexander ,Associate Profes...
 
INSULIN.pptx
INSULIN.pptxINSULIN.pptx
INSULIN.pptx
 
Antidiabetic drugs
Antidiabetic drugsAntidiabetic drugs
Antidiabetic drugs
 
antidiabeticdrugs-150825103952-lva1-app6892.pdf
antidiabeticdrugs-150825103952-lva1-app6892.pdfantidiabeticdrugs-150825103952-lva1-app6892.pdf
antidiabeticdrugs-150825103952-lva1-app6892.pdf
 
Lesson plan of teaching and learning.pptx
Lesson plan of teaching and learning.pptxLesson plan of teaching and learning.pptx
Lesson plan of teaching and learning.pptx
 
Antidiabetic agents
Antidiabetic agentsAntidiabetic agents
Antidiabetic agents
 
Insulin
InsulinInsulin
Insulin
 
Assessment Of Pancreatic Hormones In Diabetes Mellitus & Non-diabetes Mellitu...
Assessment Of Pancreatic Hormones In Diabetes Mellitus & Non-diabetes Mellitu...Assessment Of Pancreatic Hormones In Diabetes Mellitus & Non-diabetes Mellitu...
Assessment Of Pancreatic Hormones In Diabetes Mellitus & Non-diabetes Mellitu...
 

Mehr von Jasmine Chaudhary

Oral Hypoglycemic Agent (1).pdf
Oral Hypoglycemic Agent (1).pdfOral Hypoglycemic Agent (1).pdf
Oral Hypoglycemic Agent (1).pdfJasmine Chaudhary
 
Fundamentals of Volumetric Analysis.pdf
Fundamentals of Volumetric Analysis.pdfFundamentals of Volumetric Analysis.pdf
Fundamentals of Volumetric Analysis.pdfJasmine Chaudhary
 
Steroids Nomenclature.pdf
Steroids Nomenclature.pdfSteroids Nomenclature.pdf
Steroids Nomenclature.pdfJasmine Chaudhary
 
Primary and Secondary standards.pdf
Primary and Secondary standards.pdfPrimary and Secondary standards.pdf
Primary and Secondary standards.pdfJasmine Chaudhary
 
Antihyperlipidemic.pdf
Antihyperlipidemic.pdfAntihyperlipidemic.pdf
Antihyperlipidemic.pdfJasmine Chaudhary
 
Antihypertensive Drugs.pdf
Antihypertensive Drugs.pdfAntihypertensive Drugs.pdf
Antihypertensive Drugs.pdfJasmine Chaudhary
 
Errors in Pharmaceutical analysis.pdf
Errors in Pharmaceutical analysis.pdfErrors in Pharmaceutical analysis.pdf
Errors in Pharmaceutical analysis.pdfJasmine Chaudhary
 
ANTICANCER- Part II.pptx
ANTICANCER- Part II.pptxANTICANCER- Part II.pptx
ANTICANCER- Part II.pptxJasmine Chaudhary
 
Adrenoreceptor Blockers.pdf
Adrenoreceptor Blockers.pdfAdrenoreceptor Blockers.pdf
Adrenoreceptor Blockers.pdfJasmine Chaudhary
 
Sympathomimetic Drugs.ppt
Sympathomimetic Drugs.pptSympathomimetic Drugs.ppt
Sympathomimetic Drugs.pptJasmine Chaudhary
 
PARASYMPATHOMIMETIC DRUGS (Lecture 3).pdf
PARASYMPATHOMIMETIC DRUGS (Lecture 3).pdfPARASYMPATHOMIMETIC DRUGS (Lecture 3).pdf
PARASYMPATHOMIMETIC DRUGS (Lecture 3).pdfJasmine Chaudhary
 

Mehr von Jasmine Chaudhary (20)

Antacids.pdf
Antacids.pdfAntacids.pdf
Antacids.pdf
 
Non-aq. Titration.pdf
Non-aq. Titration.pdfNon-aq. Titration.pdf
Non-aq. Titration.pdf
 
Oral Hypoglycemic Agent (1).pdf
Oral Hypoglycemic Agent (1).pdfOral Hypoglycemic Agent (1).pdf
Oral Hypoglycemic Agent (1).pdf
 
Fundamentals of Volumetric Analysis.pdf
Fundamentals of Volumetric Analysis.pdfFundamentals of Volumetric Analysis.pdf
Fundamentals of Volumetric Analysis.pdf
 
Progesterone.pdf
Progesterone.pdfProgesterone.pdf
Progesterone.pdf
 
Estrogen.pdf
Estrogen.pdfEstrogen.pdf
Estrogen.pdf
 
Testosterone.pdf
Testosterone.pdfTestosterone.pdf
Testosterone.pdf
 
Steroids Nomenclature.pdf
Steroids Nomenclature.pdfSteroids Nomenclature.pdf
Steroids Nomenclature.pdf
 
Antianginal Drugs.pdf
Antianginal Drugs.pdfAntianginal Drugs.pdf
Antianginal Drugs.pdf
 
Primary and Secondary standards.pdf
Primary and Secondary standards.pdfPrimary and Secondary standards.pdf
Primary and Secondary standards.pdf
 
Antihyperlipidemic.pdf
Antihyperlipidemic.pdfAntihyperlipidemic.pdf
Antihyperlipidemic.pdf
 
Antihypertensive Drugs.pdf
Antihypertensive Drugs.pdfAntihypertensive Drugs.pdf
Antihypertensive Drugs.pdf
 
Errors in Pharmaceutical analysis.pdf
Errors in Pharmaceutical analysis.pdfErrors in Pharmaceutical analysis.pdf
Errors in Pharmaceutical analysis.pdf
 
ANTICANCER- Part II.pptx
ANTICANCER- Part II.pptxANTICANCER- Part II.pptx
ANTICANCER- Part II.pptx
 
ANTICANCER.pdf
ANTICANCER.pdfANTICANCER.pdf
ANTICANCER.pdf
 
H2 antagonist.pdf
H2 antagonist.pdfH2 antagonist.pdf
H2 antagonist.pdf
 
Histamine.pdf
Histamine.pdfHistamine.pdf
Histamine.pdf
 
Adrenoreceptor Blockers.pdf
Adrenoreceptor Blockers.pdfAdrenoreceptor Blockers.pdf
Adrenoreceptor Blockers.pdf
 
Sympathomimetic Drugs.ppt
Sympathomimetic Drugs.pptSympathomimetic Drugs.ppt
Sympathomimetic Drugs.ppt
 
PARASYMPATHOMIMETIC DRUGS (Lecture 3).pdf
PARASYMPATHOMIMETIC DRUGS (Lecture 3).pdfPARASYMPATHOMIMETIC DRUGS (Lecture 3).pdf
PARASYMPATHOMIMETIC DRUGS (Lecture 3).pdf
 

KĂźrzlich hochgeladen

Keynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designKeynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designMIPLM
 
Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Celine George
 
Procuring digital preservation CAN be quick and painless with our new dynamic...
Procuring digital preservation CAN be quick and painless with our new dynamic...Procuring digital preservation CAN be quick and painless with our new dynamic...
Procuring digital preservation CAN be quick and painless with our new dynamic...Jisc
 
What is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERPWhat is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERPCeline George
 
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxiammrhaywood
 
Full Stack Web Development Course for Beginners
Full Stack Web Development Course  for BeginnersFull Stack Web Development Course  for Beginners
Full Stack Web Development Course for BeginnersSabitha Banu
 
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTSGRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTSJoshuaGantuangco2
 
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdf
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdfInclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdf
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdfTechSoup
 
Barangay Council for the Protection of Children (BCPC) Orientation.pptx
Barangay Council for the Protection of Children (BCPC) Orientation.pptxBarangay Council for the Protection of Children (BCPC) Orientation.pptx
Barangay Council for the Protection of Children (BCPC) Orientation.pptxCarlos105
 
Influencing policy (training slides from Fast Track Impact)
Influencing policy (training slides from Fast Track Impact)Influencing policy (training slides from Fast Track Impact)
Influencing policy (training slides from Fast Track Impact)Mark Reed
 
Science 7 Quarter 4 Module 2: Natural Resources.pptx
Science 7 Quarter 4 Module 2: Natural Resources.pptxScience 7 Quarter 4 Module 2: Natural Resources.pptx
Science 7 Quarter 4 Module 2: Natural Resources.pptxMaryGraceBautista27
 
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATIONTHEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATIONHumphrey A BeĂąa
 
Roles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in PharmacovigilanceRoles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in PharmacovigilanceSamikshaHamane
 
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...Nguyen Thanh Tu Collection
 
How to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERPHow to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERPCeline George
 
ANG SEKTOR NG agrikultura.pptx QUARTER 4
ANG SEKTOR NG agrikultura.pptx QUARTER 4ANG SEKTOR NG agrikultura.pptx QUARTER 4
ANG SEKTOR NG agrikultura.pptx QUARTER 4MiaBumagat1
 
Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Celine George
 

KĂźrzlich hochgeladen (20)

Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
 
FINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptx
FINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptxFINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptx
FINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptx
 
Keynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designKeynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-design
 
Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17
 
Procuring digital preservation CAN be quick and painless with our new dynamic...
Procuring digital preservation CAN be quick and painless with our new dynamic...Procuring digital preservation CAN be quick and painless with our new dynamic...
Procuring digital preservation CAN be quick and painless with our new dynamic...
 
What is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERPWhat is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERP
 
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
 
Full Stack Web Development Course for Beginners
Full Stack Web Development Course  for BeginnersFull Stack Web Development Course  for Beginners
Full Stack Web Development Course for Beginners
 
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTSGRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
 
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdf
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdfInclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdf
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdf
 
Barangay Council for the Protection of Children (BCPC) Orientation.pptx
Barangay Council for the Protection of Children (BCPC) Orientation.pptxBarangay Council for the Protection of Children (BCPC) Orientation.pptx
Barangay Council for the Protection of Children (BCPC) Orientation.pptx
 
Influencing policy (training slides from Fast Track Impact)
Influencing policy (training slides from Fast Track Impact)Influencing policy (training slides from Fast Track Impact)
Influencing policy (training slides from Fast Track Impact)
 
Science 7 Quarter 4 Module 2: Natural Resources.pptx
Science 7 Quarter 4 Module 2: Natural Resources.pptxScience 7 Quarter 4 Module 2: Natural Resources.pptx
Science 7 Quarter 4 Module 2: Natural Resources.pptx
 
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATIONTHEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
 
Roles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in PharmacovigilanceRoles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in Pharmacovigilance
 
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
 
How to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERPHow to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERP
 
ANG SEKTOR NG agrikultura.pptx QUARTER 4
ANG SEKTOR NG agrikultura.pptx QUARTER 4ANG SEKTOR NG agrikultura.pptx QUARTER 4
ANG SEKTOR NG agrikultura.pptx QUARTER 4
 
Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17
 
LEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptx
LEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptxLEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptx
LEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptx
 

Insulin.pdf

  • 2. • Insulin is a polypeptide hormone secreted from beta cells of Islets of Langerhans of pancreas. • It is mainly responsible for regulating blood glucose level in the body by controlling carbohydrate, fat and protein metabolism. • The normal blood glucose level is (As per ADA) • If the blood sugar level becomes low, it leads to hypoglycemia and if it get increases, it leads to hyperglycemia or DIABETES MELLITUS. • Diabetes mellitus is derived from the Greek word diabetes meaning siphon - to pass through and the Latin word mellitus meaning honey or sweet. This is because in diabetes excess sugar is found in blood as well as the urine. Normal person Diabetic person Fasting 70-100mg/dl 80-130mg/dl Post prandial Less than 140mg/dl Less than 180mg/dl
  • 3. Islets of Langerhans δ-cells β-cells P-cells Îą-cells Increase glucose level Decrease glucose level Secrete glucagon Secrete Somatostatin Inhibit both insulin and glucagon Pancreatic polypeptide Secrete insulin
  • 4. • Diabetes mellitus is a group of metabolic diseases characterized by hyperglycemia resulting from defects in insulin secretion, insulin action, or both. • If left untreated, it may lead to several complications like diabetic nephropathy, retinopathy, heart diseases, stroke, foot ulcers and damage to eyes. • Diabetes generally occurs, when pancreas is not able to either produce sufficient insulin or body is not able to utilize sufficient insulin or both. • Depending on, diabetes mellitus is divided into 2 main types  Insulin dependent diabetes mellitus (IDDM)/ Type-I DM  Non-insulin dependent diabetes mellitus (NIDDM)/ Type-2 DM
  • 5. Type-I DM • Pancreas lack the ability to synthesize/release insulin. • Also known as Juvenile diabetes because it often begins in childhood. • The cause is generally unknown. • It is mainly an autoimmune condition which is caused by body attacking its own pancreas with antibodies so damaged pancreas is not able to produce enough insulin. • Insulin therapy is the only treatment. • No family history so may or may not be hereditary. • Obesity is generally not the cause.
  • 6. Type-II DM • In this body is incapable of utilizing the synthesized insulin or insulin secretion is not sufficient. • Also known as adult onset diabetes as it generally begins after adulthood. • Primary cause is excessive body weight and not proper exercise. • Oral hypoglycemic agents can be helpful. • Most common type and generally hereditary. A third type of diabetes mellitus generally occurs during pregnancy and it is known as GESTATIONAL diabetes. • It may occur in a woman without a previous history of diabetes.
  • 7. • Unexplained weight loss and sometimes weight gain • Polydipsia • Polyphagia • Polyuria • Excessive fatigue/ lethargy • Slow healing • Excessive sleep • Blurred vision • Glucosuria • Itchy skin • Ketonemia • Astouria • Prolonged high glucose level may lead to glucose absorption in lens of eye, leading to change in shape and result in vision changes.
  • 8. Insulin • Longest polypeptide of known structure (Mol wt: more than 6000). • Term insulin was coined by DeMeyer in 1909 and sequence of amino acids in insulin was characterized by Sanger in 1956. Structure of Insulin Made up of 2 Amino acid chain: Chain A and Chain B Chain A : consists of 21 Aa Chain B: Consists of 30 Aa So Total 51 Aa are present in insulin. Both chains are linked to each other by 2 disulfide bonds • Ist Bridge: 7th Aa (Cysteine) of chain A with 7th Aa (Cysteine) of Chain b • 2nd Bridge: 20th Aa (Cysteine) of chain A with 19th Aa (Cysteine) of Chain b • 3rd bridge: within chain A itself (6th and 11th Aa of chain A)
  • 10. SAR of insulin • Removal of Aa from chain A reduce activity. • Aa from 1-6 and 26-30 from chain B: can be removed without significantly effecting activity. • There should be specific relationship between confirmation and activity of insulin. So, any change in configuration leads to loss of activity. • Any modification of side chain carboxylic or tyrosine residues decrease activity.
  • 11. Biosynthesis of Insulin Preproinsulin Preinsulin (Precursor present in ribosomes of ER of pancreatic beta cells) Protease Insulin +4 Aa+ C-peptide Combine with Zn and stored in form of granulated Zn vesicles Breakage of storage vesicles Release of insulin Ca
  • 12. Physiological functions of insulin Carbohydrate metabolism: In normal amount, regulates gluconeogenesis and glycogenolysis. • Deficiency may lead to increased gluconeogenesis and glycogenolysis leading to increased glucose level. Fat metabolism: Promotes lipogenesis • Deficiency may lead to increased mobilization of fats from adipose tissue into blood, thereby increasing free fatty acid in blood which in turn increase acetoacetic acid, ketone bodies, beta-hydroxy butyric acid leading to ketoacidosis. Protein metabolism • Deficiency leads to breaking of proteins from muscles leading to muscle
  • 13. Limitations of Insulin • Insulin can’t be taken orally due to its proteinaceous nature so metabolized by enzymes like pepsin, trypsin. • On long term therapy, oedema at site of injection. • Insulin therapy fails to give expected results, if there is no diet control/exercise. • If dose of insulin is not scheduled properly, fluctuations in blood glucose levels leads to visual disturbances like cataract and there may chances of hypoglycemic shock.